Ylures sans sel,evolution en phosphoranes et equilibre ylure ⇌ phosphorane : I Synthese et structure

Synthesis of new salt-free ylids $\text{9}$,$\text{12}$ to $\text{16}$, $\text{19}$, $\text{20}$, $\text{22}$, $\text{27}$ and $\text{29}$ and phoiphoranes $\text{10}$, $\text{17}$, $\text{18}$, $\text{21}$, $\text{23}$, $\text{30}$ to $\text{33}$ by addition of a trivalent phosphorus compound (phosphites and amino-phosphines ) $\text{1}$ to $\text{7}$ with dimethyl acetylencedicartboxylate in presence of a protic trapping reagent are described. The results are consistent with trapping of carbanionic species. In relation with the. cyclic of acyclic structure of the triivalent phosphorus compound and the protic trapping reagent ie : methanol, phenol, carboxylic acid, etc.., several pathways are involved. Clearly), three phenomena are shown : one can obtain an ylid via a phosphorane or conversely a phosphorane via an ylid or an equilibrium Phoiphorane ? ylid. Results are dealing with thermodynamic or kinetically controlled reactions.     

C3 cyclopolymerization. I. Is the cyclopolymerization of 1,3-bis(p-vinylphenyl)-propane by means of radical or anionic initiators possible?

Polymerization of 1,3-bis(p-vinylphenyl) propane (St-C₃-St) was investigated by using radical and anionic initiators. Radical polymerization yielded linear polymer with pendant styryl groups in pertinent conditions without gelation. Anionic polymerization with n-butyllithium and sodium naphthalene produced insoluble polymers that, according to infrared (IR) spectroscopy, had no cyclized units. On the other hand, phenylmagnesium bromide gave soluble polymer in HMPA-benzene mixed solvent. Zero-valent nickel catalyst also gave soluble polymer. The soluble polymers could be analyzed by several spectroscopies, and it was confirmed that those obtained by anionic and coordination polymerization had no [3.3]paracyclophane units in the main chain. From these results it was concluded that cationic propagation could be assumed if the polymer Of St-C₃-St contained [3.3]paracyclophane units in the main chain.     

Synthesis and Investigation of Indium Dodecatungstosilicate

Indium dodecatungstosilicate of the composition [In(OH)⋅5H₂O]₂ [SiW₁₂O₄₀]⋅H₂O is synthesized and studied by means of IR spectroscopy, thermogravimetry, and X-ray phase analysis. The crystals of this compound are triclinic, space group P1, a 13.079(3), b 13.795(3), c 13.967(3) Å, α 90.08(3)°, β 103.76(3)°, ψ107.76(3)°, Z 2, and π_calc 4.900 g cm⁻³.__________Translated from Zhurnal Obshchei Khimii, Vol. 75, No. 1, 2005, pp. 21–23.Original Russian Text Copyright © 2005 by Kaziev, Dutov, Quinones, Ita, Sychkin.     

Speciation of metabolites of selenate in rats by HPLC-ICP-MS

The metabolic pathway for and metabolites of selenium (Se) administered intravenously to rats in the form of selenate at a dose of 0.3 mg Se kg-1 body weight were studied by speciating Se in the bloodstream, liver and urine by HPLC-inductively coupled argon plasma mass spectrometry. Selenate was not taken up by red blood cells (RBCs) and disappeared from the bloodstream much faster than selenite, without any change in its chemical form before it disappeared from the plasma. Selenium excreted into the urine after the administration of selenate showed different patterns from those of selenite in both amounts and chemical forms. With the selenate group, the concentration of Se in urine was highest at 0-6 h and the chemical species of Se was selenate at 0-6 h; thereafter a monomethylselenol-related Se compound (MMSe*) and trimethylselenonium ions (TMSe) appeared, selenate not being excreted after 6 h. On the other hand, in the selenite group, the concentration of Se peaked at 6-12 h, and the chemical species of Se were MMSe* and TMSe. Selenate was reduced in vitro on incubation in either a liver homogenate or supernatant fraction, although much more slowly than in the whole body. Selenate was not reduced by glutathione or dithiothreitol. The results suggest that in contrast to selenite, which is taken up by and reduced in RBCs, and then transferred to the liver, approximately 20% of the selenate administered to rats was excreted into the urine without any change in its chemical form with the present dose, and the major portion of selenate was taken up by the liver, reduced and then utilized for the synthesis of selenoproteins or excreted into the urine after being methylated.